Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity

Jie Zhou1, Run-Cong Nie1,2, Yi-Xin Yin1

  • 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

Disease Markers
|November 24, 2022
PubMed

Insights

Cisplatin chemotherapy causes kidney damage through oxidative stress. Natural antioxidants show promise in preventing this nephrotoxicity by reducing harmful reactive oxygen species (ROS).

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Cisplatin is a vital chemotherapy drug, but its use is limited by severe nephrotoxicity.
  • Oxidative stress, driven by reactive oxygen species (ROS), is a key mechanism in cisplatin-induced kidney damage.
  • ROS trigger cellular damage pathways like apoptosis and necrosis, contributing to organ dysfunction.

Purpose of the Study:

  • To review the mechanisms of intracellular ROS generation by cisplatin.
  • To explore how natural antioxidants counteract cisplatin-induced nephrotoxicity.
  • To provide a foundation for understanding cisplatin nephrotoxicity and the role of antioxidants.

Main Methods:

  • Literature review focusing on cisplatin's effects on cellular redox balance.
  • Analysis of studies investigating ROS generation pathways (antioxidant depletion, enzyme/CYP system damage, mitochondrial crosstalk).
  • Examination of research on natural antioxidant interventions against cisplatin nephrotoxicity.

Main Results:

  • Cisplatin induces ROS accumulation via endogenous antioxidant depletion, antioxidant enzyme destruction, and endoplasmic reticulum-mitochondria crosstalk.
  • Mitochondrial crosstalk involving ROS and Ca2+ exacerbates cellular damage.
  • The cytochrome P450 system's destruction in the endoplasmic reticulum contributes to oxidative stress.
  • Natural antioxidants effectively mitigate cisplatin-induced nephrotoxicity by scavenging ROS and influencing non-redox pathways.

Conclusions:

  • Understanding cisplatin-induced ROS generation is crucial for managing nephrotoxicity.
  • Natural antioxidants offer a promising therapeutic strategy to protect against cisplatin-induced kidney damage.
  • This review supports further research into natural antioxidants for clinical applications alongside cisplatin therapy.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
245
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K